The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Responsible implementation of expanded carrier screening
Open accessAbstract
This document of the European Society of Human Genetics contains recommendations regarding responsible implementation of expanded carrier screening. Carrier screening is defined here as the detection of carrier status of recessive diseases in couples or persons who do not have an a priori increased risk of being a carrier based on their or their partners' personal or family history. Expanded carrier screening offers carrier screening for multiple autosomal and X-linked recessive disorders, facilitated by new genetic testing technologies, and allows testing of individuals regardless of ancestry or geographic origin. Carrier screening aims to identify couples who have an increased risk of having an affected child in order to facilitate informed reproductive decision making. In previous decades, carrier screening was typically performed for one or few relatively common recessive disorders associated with significant morbidity, reduced life-expectancy and often because of a considerable higher carrier frequency in a specific population for certain diseases. New genetic testing technologies enable the expansion of screening to multiple conditions, genes or sequence variants. Expanded carrier screening panels that have been introduced to date have been advertised and offered to health care professionals and the public on a commercial basis. This document discusses the challenges that expanded carrier screening might pose in the context of the lessons learnt from decades of population-based carrier screening and in the context of existing screening criteria. It aims to contribute to the public and professional discussion and to arrive at better clinical and laboratory practice guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Paradox of Choice: Why More Is Less
Schwartz, B. N. (2004) · Works - Scholarship, Research, & Creative Expression (Swarthmore College) · Cited by 2,512
Andermann, A. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.050112 · Cited by 903
The Human Gene Mutation Database: 2008 update
Stenson, P. D., Mort, M., Ball, E. V., Howells, K., Phillips, A. D., Thomas, N. S., & Cooper, D. N. (2009) · Genome Medicine · doi:10.1186/gm13 · Cited by 873
Bacon, B. R., Adams, P. C., Kowdley, K. V., Powell, L. W., & Tavill, A. S. (2011) · Hepatology · doi:10.1002/hep.24330 · Cited by 723
Carrier testing for severe childhood recessive diseases by next-generation sequencing
Bell, C. J., Dinwiddie, D. L., Miller, N. A., Hateley, S. L., Ganusova, E. E., Mudge, J., Langley, R. J., Zhang, L., Lee, C. C., Schilkey, F. D., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001756 · Cited by 706
The Genome of the Netherlands Consortium (2014) · Nature Genetics · doi:10.1038/ng.3021 · Cited by 659
EASL clinical practice guidelines for HFE hemochromatosis
European Association for the Study of the Liver (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.001 · Cited by 587
Brownstein, C. A., Beggs, A. H., Homer, N., Merriman, B., Yu, T. W., Flannery, K. C., DeChene, E. T., Towne, M. C., Savage, S. K., Price, E. N., et al. (2014) · Genome Biology · doi:10.1186/gb-2014-15-3-r53 · Cited by 432
Self-citationEdwards, J. G., Feldman, G., Goldberg, J., Gregg, A. R., Norton, M. E., Rose, N. C., Schneider, A., Stoll, K., Wapner, R., & Watson, M. S. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000666 · Cited by 358
on behalf of the European Society of Human Genetics (ESHG) and the American Society of Human Genetics (ASHG), Dondorp, W., de Wert, G., Bombard, Y., Bianchi, D. W., Bergmann, C., Borry, P., Chitty, L. S., Fellmann, F., Forzano, F., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.57 · Cited by 349
Self-citationTargeted Next-Generation Sequencing can Replace Sanger Sequencing in Clinical Diagnostics
Sikkema-Raddatz, B., Johansson, L. F., de Boer, E. N., Almomani, R., Boven, L. G., van den Berg, M. P., van Spaendonck-Zwarts, K. Y., van Tintelen, J. P., Sijmons, R. H., Jongbloed, J. D. H., et al. (2013) · Human Mutation · doi:10.1002/humu.22332 · Cited by 300
Fragile X syndrome: Diagnostic and carrier testing
Sherman, S., Pletcher, B. A., & Driscoll, D. A. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000182468.22666.dd · Cited by 277
Lazarin, G. A., Haque, I. S., Nazareth, S., Iori, K., Patterson, A. S., Jacobson, J. L., Marshall, J. R., Seltzer, W. K., Patrizio, P., Evans, E. A., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2012.114 · Cited by 271
Newborn and carrier screening for spinal muscular atrophy
Prior, T. W., Snyder, P. J., Rink, B. D., Pearl, D. K., Pyatt, R. E., Mihal, D. C., Conlan, T., Schmalz, B., Montgomery, L., Ziegler, K., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33474 · Cited by 268
Non-syndromic recessive auditory neuropathy is the result of mutations in the otoferlin (OTOF) gene
Varga, R., Kelley, P. M., Keats, B. J., Starr, A., Leal, S. M., Cohn, E., & Kimberling, W. J. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.1.45 · Cited by 252
ACMG position statement on prenatal/preconception expanded carrier screening
Grody, W. W., Thompson, B. H., Gregg, A. R., Bean, L. H., Monaghan, K. G., Schneider, A., & Lebo, R. V. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.47 · Cited by 248
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers
Anheim, M., Elbaz, A., Lesage, S., Durr, A., Condroyer, C., Viallet, F., Pollak, P., Bonaïti, B., Bonaïti-Pellié, C., & Brice, A. (2012) · Neurology · doi:10.1212/wnl.0b013e318245f476 · Cited by 238
Carrier screening for Beta-thalassaemia: a review of international practice
Cousens, N. E., Gaff, C. L., Metcalfe, S. A., & Delatycki, M. B. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.90 · Cited by 225
Self-citationPopulation-based genetic screening for reproductive counseling: the Tay-Sachs disease model
Kaback, M. M. (2000) · European Journal of Pediatrics · doi:10.1007/pl00014401 · Cited by 212
Uptake of cystic fibrosis testing in primary care: supply push or demand pull?
Bekker, H., Modell, M., Denniss, G., Silver, A., Mathew, C., Bobrow, M., & Marteau, T. (1993) · BMJ · doi:10.1136/bmj.306.6892.1584 · Cited by 198
Saffi, M., & Howard, N. (2015) · Public Health Genomics · doi:10.1159/000430837 · Cited by 159
Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases
Scott, S. A., Edelmann, L. J., Liu, L., Luo, M., Desnick, R. J., & Kornreich, R. (2010) · Human Mutation · doi:10.1002/humu.21327 · Cited by 153
Population genetic screening programmes: principles, techniques, practices, and policies
Godard, B., ten Kate, L. P., Evers‐Kiebooms, G., & Aymé, S. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201113 · Cited by 152
Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels
Lazarin, G. A., Hawthorne, F. A., Collins, N. S., Platt, E. A., Evans, E. A., & Haque, I. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114391 · Cited by 149
Couple screening for cystic fibrosis
Wald, N. (1991) · The Lancet · doi:10.1016/0140-6736(91)92605-2 · Cited by 147
Cao, A., Rosatelli, M. C., Monni, G., & Galanello, R. (2002) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(01)00006-7 · Cited by 146
What influences participation in genetic carrier testing?
Hall, J. P., Fiebig, D. G., King, M. T., Hossain, I., & Louviere, J. J. (2005) · Journal of Health Economics · doi:10.1016/j.jhealeco.2005.09.002 · Cited by 137
23. The Dor Yeshorim story: Community-based carrier screening for Tay-Sachs disease
Ekstein, J., & Katzenstein, H. M. (2001) · Advances in genetics · doi:10.1016/s0065-2660(01)44087-9 · Cited by 128
Serious genetic disorders: Can or should they be defined?*
Wertz, D. C., & Knoppers, B. M. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10212 · Cited by 128
Couple screening for cystic fibrosis
Wald, N., George, L., Wald, N. J., & MacKenzie, I. Z. (1993) · The Lancet · doi:10.1016/0140-6736(93)92403-g · Cited by 121
Weiss, M. M., van der Zwaag, B., Jongbloed, J. D. H., Vogel, M. J., Brüggenwirth, H. T., Deprez, R. H. L., Mook, O. R. F., Ruivenkamp, C. A. L., van Slegtenhorst, M. A., van den Wijngaard, A., et al. (2013) · Human Mutation · doi:10.1002/humu.22368 · Cited by 119
Analytical validation of whole exome and whole genome sequencing for clinical applications
Linderman, M. D., Brandt, T., Edelmann, L. J., Jabado, O., Kasai, Y., Kornreich, R., Mahajan, M. C., Shah, H., Kasarskis, A., & Schadt, E. E. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-20 · Cited by 115
Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up
Study, U. C. F. F.-U., Axworthy, D., Marteau, T. M., Brock, D. J. H., & Bobrow, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91683-9 · Cited by 110
Preconception care and genetic risk: ethical issues
de Wert, G. M. W. R., Dondorp, W., & Knoppers, B. M. (2011) · Journal of Community Genetics · doi:10.1007/s12687-011-0074-9 · Cited by 106
Self-citationA universal carrier test for the long tail of Mendelian disease
Srinivasan, B. S., Evans, E. A., Flannick, J., Patterson, A. S., Chang, C. C., Pham, T., Young, S., Kaushal, A., Lee, J., Jacobson, J. L., et al. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2010.05.012 · Cited by 105
BENN, P. A., Chapman, A. R., Erickson, K., DeFrancesco, M. S., Wilkins-Haug, L. E., EGAN, J. F. X., & Schulkin, J. A. (2013) · Prenatal Diagnosis · doi:10.1002/pd.4272 · Cited by 104
Effects of genetic screening on perceptions of health: a pilot study.
Marteau, T. M., van Duijn, M., & Ellis, I. (1992) · Journal of Medical Genetics · doi:10.1136/jmg.29.1.24 · Cited by 104
The ‘thousand-dollar genome’: an ethical exploration
Dondorp, W., & de Wert, G. M. W. R. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.73 · Cited by 97
Self-citationPopulation-based carrier screening for cystic fibrosis: a systematic review of 23 years of research
Ioannou, L., McClaren, B., Massie, J., Lewis, S., Metcalfe, S. A., Forrest, L. E., & Delatycki, M. B. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.125 · Cited by 95
Self-citationHereditary effects of radiation
(1993) · Report of the United Nations Scientific Committee on the Effects of Atomic Radiation · doi:10.18356/4d1086d8-en · Cited by 95
Comprehensive Carrier Screening and Molecular Diagnostic Testing for Recessive Childhood Diseases
Kingsmore, S. F. (2012) · PLoS Currents · doi:10.1371/4f9877ab8ffa9 · Cited by 92
On the future of genetic risk assessment
Ropers, H. (2012) · Journal of Community Genetics · doi:10.1007/s12687-012-0092-2 · Cited by 91
Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening.
Clayton, E. W., Hannig, V., Pfotenhauer, J. P., Parker, R., Campbell, P. W., & Phillips, J. A. (1996) · PubMed Central · Cited by 89
Benchmarks for Cystic Fibrosis carrier screening: A European consensus document
Castellani, C., Maçek, M., Cassiman, J. J., Duff, A. J. A., Massie, J., ten Kate, L. P., Barton, D. E., Cutting, G. R., Dallapiccola, B., Dequeker, E. M. C., et al. (2010) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2010.02.005 · Cited by 86
Stigmatization of carrier status: social implications of heterozygote genetic screening programs.
Kenen, R. H., & Schmidt, R. M. (1978) · American Journal of Public Health · doi:10.2105/ajph.68.11.1116 · Cited by 84
Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years
Modell, B., Petrou, M., Layton, M., Slater, C., Ward, R. H. T., Rodeck, C. H., Varnavides, L., Nicolaides, K. H., Gibbons, S., Fitches, A. C., et al. (1997) · BMJ · doi:10.1136/bmj.315.7111.779 · Cited by 81
Carrier Screening for Gaucher Disease
Zuckerman, S., Lahad, A., Shmueli, A., Zimran, A., Peleg, L., Orr‐Urtreger, A., Levy‐Lahad, E., & Sagi, M. (2007) · JAMA · doi:10.1001/jama.298.11.1281 · Cited by 79
Expanded carrier screening in reproductive healthcare: perspectives from genetics professionals
Cho, D., McGowan, M. L., Metcalfe, J., & Sharp, R. R. (2013) · Human Reproduction · doi:10.1093/humrep/det091 · Cited by 79
Raz, A. E., & Vizner, Y. (2008) · Social Science & Medicine · doi:10.1016/j.socscimed.2008.07.011 · Cited by 71
Barlow-Stewart, K., Burnett, L., Proos, A., Howell, V, Huq, F., Lazarus, R., & Aizenberg, H. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.4.e45 · Cited by 66
Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners.
Mennie, M., Compton, M. E., Gilfillan, A., Liston, W. A., Pullen, I., Whyte, D. A., & Brock, D. J. H. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.7.543 · Cited by 62
der Wal, J. T. G.-V., Manniën, J., Ghaly, M. M., Verhoeven, P. S., Hutton, E. K., & Reinders, H. S. (2013) · Midwifery · doi:10.1016/j.midw.2013.04.001 · Cited by 58
McClaren, B., Delatycki, M. B., Collins, V., Metcalfe, S. A., & Aitken, M. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201965 · Cited by 57
Self-citationMetcalfe, S. A., Jacques, A., Archibald, A. D., Burgess, T., Collins, V., Henry, A., McNamee, K. M., Sheffield, L. J., Slater, H. R., Wake, S., et al. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31817c036e · Cited by 56
Self-citationChen, L., & Goodson, P. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e3180986767 · Cited by 55
Carrier screening in preconception consultation in primary care
Metcalfe, S. A. (2011) · Journal of Community Genetics · doi:10.1007/s12687-011-0071-z · Cited by 55
Self-citationIonizing radiation and genetic risks
Sankaranarayanan, K. (1998) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(98)00012-x · Cited by 53
Rigter, T., Henneman, L., Kristoffersson, U., Hall, A., Yntema, H. G., Borry, P., Tönnies, H., Waisfisz, Q., Elting, M. W., Dondorp, W., et al. (2013) · Human Mutation · doi:10.1002/humu.22370 · Cited by 53
Self-citationReady, K. J., Haque, I. S., Srinivasan, B. S., & Marshall, J. R. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.007 · Cited by 51
Measuring informed choice in population-based reproductive genetic screening: a systematic review
Ames, A., Metcalfe, S. A., Archibald, A. D., Duncan, R. E., & Emery, J. D. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.89 · Cited by 49
Self-citationLakeman, P., Plass, A. M., Henneman, L., Bezemer, P. D., Cornel, M. C., & ten Kate, L. P. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e318188d04c · Cited by 47
Self-citationHenneman, L., Bramsen, I., van Kempen, L., van Acker, M. B., Pals, G., van der Horst, H. E., Adèr, H. J., van der Ploeg, H. M., & ten Kate, L. P. (2003) · Public Health Genomics · doi:10.1159/000069540 · Cited by 45
Self-citationLakeman, P., Plass, A. M., Henneman, L., Bezemer, P. D., Cornel, M. C., & ten Kate, L. P. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.1 · Cited by 45
Self-citationPayne, Y., Williams, M. A., Cheadle, J. P., Stott, N. C. H., Stobbart-Rowlands, M., Shickle, D., West, G., Meredith, L., Goodchild, M., Harper, P. S., et al. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb02445.x · Cited by 44
Evaluation of a multi‐disease carrier screening programme in Ashkenazi Jewish high schools
Ioannou, L., Massie, J., Lewis, S., Petrou, V., Gason, A. A., Metcalfe, S. A., Aitken, M., Bankier, A., & Delatycki, M. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01459.x · Cited by 42
Self-citationPopulation-Based Genetic Screening for Cystic Fibrosis: Attitudes and Outcomes
Ioannou, L., Massie, J., Collins, V., McClaren, B., & Delatycki, M. B. (2010) · Public Health Genomics · doi:10.1159/000276544 · Cited by 41
Mathijssen, I. B., Henneman, L., van Eeten-Nijman, J. M. C., Lakeman, P., Ottenheim, C. P. E., Redeker, E. J. W., Ottenhof, W., Meijers-Heijboer, H. E. J., & van Maarle, M. C. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2015.01.004 · Cited by 40
Self-citationAttitudes toward prenatal screening and testing for Fragile X
Fanos, J. H., Spangner, K. A., & Musci, T. J. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000200158.66554.7f · Cited by 39
Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening?
Holtkamp, K. C. A., van Maarle, M. C., Schouten, M. J. E., Dondorp, W., Lakeman, P., & Henneman, L. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.97 · Cited by 37
Self-citationPopulation screening for cystic fibrosis: Knowledge and emotional consequences 18 months later
Gordon, C. L., Walpole, I., Zubrick, S. R., & Bower, C. I. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20259 · Cited by 35
Tay Sachs disease carrier screening in schools: Educational alternatives and cheekbrush sampling
Gason, A. A., Metcalfe, S. A., Delatycki, M. B., Petrou, V., Sheffield, E., Bankier, A., & Aitken, M. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000187162.28070.a7 · Cited by 33
Self-citationEvaluation of cystic fibrosis carrier screening programs according to genetic screening criteria
Henneman, L., Poppelaars, F. A. M., & ten Kate, L. P. (2002) · Genetics in Medicine · doi:10.1097/00125817-200207000-00002 · Cited by 32
Self-citationBasel‐Vanagaite, L., Taub, E., Drasinover, V., Magal, N., Brudner, A., Zlotogora, J., & Shohat, M. (2008) · Genetic Testing · doi:10.1089/gte.2007.0030 · Cited by 28
Interventions to enhance informed choices among invitees of screening programmes—a systematic review
van Agt, H. M. E., Korfage, I. J., & Essink‐Bot, M. (2014) · European Journal of Public Health · doi:10.1093/eurpub/ckt205 · Cited by 28
Frumkin, A., Raz, A. E., Duvdevani, M. P., & Lieberman, S. (2011) · Social Science & Medicine · doi:10.1016/j.socscimed.2011.09.031 · Cited by 27
for the EASAC–FEAM Working Group, Fears, R., Participants in the Working Group were: Stefania Boccia, M. C., & ter Meulen, V. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.238 · Cited by 27
Janssens, S., Paepe, A. D., & Borry, P. (2012) · Journal of Community Genetics · doi:10.1007/s12687-012-0131-z · Cited by 27
Self-citationNewborn screening and carrier screening for cystic fibrosis: alternative or complementary?
Castellani, C., & Massie, J. (2013) · European Respiratory Journal · doi:10.1183/09031936.00125613 · Cited by 25
Stark, Z., Massie, J., McClaren, B., Ioannou, L., Cousens, N. E., Lewis, S., Metcalfe, S. A., & Delatycki, M. B. (2013) · Twin Research and Human Genetics · doi:10.1017/thg.2012.152 · Cited by 25
Self-citationLakeman, P., Henneman, L., Bezemer, P. D., Cornel, M. C., & ten Kate, L. P. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000232461.11153.9a · Cited by 21
Self-citationMartyn, M. M., Anderson, V. A., Archibald, A. D., Carter, R., Cohen, J., Delatycki, M. B., Donath, S. M., Emery, J. D., Halliday, J. L., Hill, M. K., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003660 · Cited by 20
Self-citationJans, S. M. P. J., de Jonge, A., Henneman, L., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.72 · Cited by 14
Self-citationCousens, N. E., Gaff, C., Delatycki, M. B., et al. (2013) · Prenatal Diagnosis · doi:10.1002/pd.4297 · Cited by 8
van der Pal, S. M., van Kesteren, N. M. C., Wouwe, J. P. V., et al. (2013) · Journal of Environmental and Public Health · doi:10.1155/2013/374831 · Cited by 7
“He didn’t say that thalassaemia might come up” — β-thalassaemia carriers’ experiences and attitudes
Cousens, N. E., Gaff, C., Metcalfe, S. A., et al. (2013) · Journal of Community Genetics · doi:10.1007/s12687-012-0136-7 · Cited by 6
Self-citation
Cited by
The future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection
Renard, M., Francis, C., Ghosh, R., Scott, A. F., Witmer, P. D., Adès, L. C., Andelfinger, G. U., Arnaud, P., Boileau, C., Callewaert, B. L., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.089 · Cited by 306
Metadata
- Authors
- Henneman, L., Borry, P., Chokoshvili, D., Cornel, M. C., van El, C. G., Forzano, F., Hall, A., Howard, H. C., Janssens, S., Kayserili, H., Lakeman, P., Lucassen, A., Metcalfe, S. A., Vidmar, L., de Wert, G., Dondorp, W. J., Peterlin, B., & on behalf of the European Society of Human Genetics (ESHG)
- Venue
- European Journal of Human Genetics
- Published
- 2016-03-16
- Volume
- 24
- Issue
- 6
- Pages
- e1-e12
- ISSN
- 1018-4813 (ISSN-L)
- 1476-5438
- OpenAlex
- W2302294685
- Cited by
- 330
- References
- 85
- FWCI
- 34.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.